Evidence map›Paper›PMID 39568084›Full record

ArticleParasites & vectors2024

Resistance intensity test (RIT): a novel bioassay for quantifying the level of acaricide resistance in Rhipicephalus microplus ticks.

Frans Jongejan, Laura Berger, Laura Homminga, Iris Hulsebos, Alita Petersen, Priscila Teixeira Ferreira, José Reck, Guilherme Klafke

Abstract read
In one paragraph

Article in Parasites & vectors, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Frans JongejanDepartment of Veterinary Tropical Diseases, Faculty of Veterinary Science, University of Pretoria, Private Bag X04, Onderstepoort, 0110, Republic of South Africa. Frans.Jongejan@up.ac.za.
Laura BergerTBD International BV, BioScience Center, Runderweg, 6,8219 PK, Lelystad, The Netherlands.
Laura HommingaTBD International BV, BioScience Center, Runderweg, 6,8219 PK, Lelystad, The Netherlands.
Iris HulsebosTBD International BV, BioScience Center, Runderweg, 6,8219 PK, Lelystad, The Netherlands.
Alita PetersenTBD International BV, BioScience Center, Runderweg, 6,8219 PK, Lelystad, The Netherlands.
Priscila Teixeira FerreiraInstituto de Pesquisas Veterinárias Desidério Finamor, Estrada Do Conde, 6000, Eldorado Do Sul, RS, 92990-000, Brazil.
José ReckInstituto de Pesquisas Veterinárias Desidério Finamor, Estrada Do Conde, 6000, Eldorado Do Sul, RS, 92990-000, Brazil.
Guilherme KlafkeInstituto de Pesquisas Veterinárias Desidério Finamor, Estrada Do Conde, 6000, Eldorado Do Sul, RS, 92990-000, Brazil.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundOne bioassay for detecting acaricide resistance in livestock ticks is the adult immersion test (AIT), wherein engorged ticks are briefly immersed into a solution of a particular acaricidal compound and examined for mortality, their egg-laying capacity and offspring hatchability in vitro. Usually, the recommended label dose or an established discriminating dose of an acaricide is used to determine high mortality (≥ 95%) of susceptible tick strains. Such a test intends to detect the presence of resistance in a tick population. However, the adult immersion test does not directly translate the bioassay results to the predicted efficacy in the field. In this paper, we used the AIT as an initial screening bioassay supplemented with the resistance intensity test (RIT), a novel larval-based bioassay, wherein the resistance level can be determined and translated to the expected field efficacy. This was done by adopting World Health Organisation (WHO) guidelines for resistance detection in mosquitoes, which combines a 1 × recommended dose with 5 × and 10 × concentrated doses to reveal low, moderate and high resistance intensity, respectively.

methodsEngorged Rhipicephalus microplus ticks were collected from cattle at six different ranches across Rio Grande do Sul, Brazil, as part of the state's acaricide resistance surveillance program. Groups of adult ticks from each field collection were subjected to the AIT from each field sample. Additionally, engorged female ticks from each ranch were allowed to lay eggs, and their larval progeny aged 14 to 28 days were then used in the RIT. Deltamethrin and a combination of cypermethrin, chlorpyrifos and piperonyl butoxide were used in both tests, and the results were statistically analysed.

resultsThe in vitro efficacy of deltamethrin against adult ticks in the AIT ranged between 8.74% and 25.38%. The corresponding RIT results on their larval progeny indicated a high resistance level. In the immersion test, the in vitro efficacy of the combination of cypermethrin, chlorpyrifos, and piperonyl butoxide against adult ticks ranged between 49.31% and 100%. The corresponding RIT results on their larval progeny indicated a similar response ranging from fully susceptible to low or moderate resistance. The Pearson correlation coefficient (r = 0.883) showed a high correlation between tick mortality at the 1 × recommended concentrations of acaricides in both tests.

conclusionsThe resistance intensity test is a valuable addition to the range of bioassays currently available for detecting acaricide resistance by determining the level of acaricide resistance. This is relevant to whether or not to continue using a particular acaricidal class for controlling cattle ticks.

Indexed as

AcaricidesBiological AssayLarvaRhipicephalusTick InfestationsAnimalsBrazilCattleCattle DiseasesChlorpyrifosDrug ResistanceFemaleNitrilesPyrethrinsAcaricidesChlorpyrifosdecamethrinNitrilesPyrethrinsAcaricide resistanceAdult immersion testBrazilCattleLarval packet testResistance intensity testTicks

Identifiers

PMID39568084
PMCPMC11580224

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.